In recent days, Invivyd announced that the U.S. FDA has cleared its Investigational New Drug application, allowing the REVOLUTION clinical program for VYD2311, a monoclonal antibody alternative to ...

South Korea's Celltrion Inc will begin commercial production of its experimental treatment for COVID-19 this month, it said on Tuesday, as it pushes ahead with clinical trials of the antibody drug.

A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's remdesivir therapy, an ...

AbCellera Biologics eyes long-term growth with a new facility, clinical trial progress, and a pivot to proprietary drug ...

Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV ...

Scientists find breast milk antibodies influence infant immune responses long-term, offering insights for future formula enhancements.

Northern Ireland biotechnology company Fusion Antibodies has been selected to proceed with a new multi-target integrated ...

He said, “We will expand integrated services that provide end-to-end support from early stages to commercial production for antibodies, ADCs (antibody-drug conjugates), mRNA (messenger RNA), and CGTs ...

IAVI has entered a strategic alliance with Minapharm and ProBioGen to expand vaccine and biologics production in Africa.

Freeze-drying is preferred for sensitive samples because it combines low-temperature processing with gentle water removal.

Global medicine and research corporation AstraZeneca plans to invest $4.5 billion to build two major manufacturing facilities in Albemarle County, establishing a new cornerstone of the company’s U.S.

Everywhere you go, you carry a population of microbes in your gastrointestinal tract that outnumber the human cells making up ...